Small Caps

Fusion Antibodies validation project with US NIC progresses
Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was progressing as planned.

Metals One completes PEA for Finland Black Schist project
Metals One announced on Friday that it has completed a preliminary economic assessment (PEA) for its Finland Black Schist Ni-Cu-Co-Zn Project, identifying the Rautavaara (R1) deposit as the key economic driver.

Celadon still seeking finance as it draws down most of facility
Celadon Pharmaceuticals reported on Friday that it has received £0. 897m of a £1m drawdown request from its committed credit facility, with the remaining £0. 1m now expected in February.

Prospex reports rise in production from Selva Malvezzi
Prospex Energy reported a significant increase in production and revenue from the Selva Malvezzi production concession in Italy on Friday, with gross revenue for the fourth quarter reaching €3. 38m, a 91% rise compared to the final three months of 2023.

Cohort completes acquisition of Aussie firm EM Solutions
Cohort announced the completed acquisition of EM Solutions on Friday, following earlier announcements in November and January.

Faron identifies final patient in BEXMAB phase two study
Faron Pharmaceuticals announced on Friday that it has identified the final patient for its BEXMAB phase two dose optimisation study in refractory or relapsed myelodysplastic syndrome (r/r MDS) and its phase one and two study in frontline high-risk (HR) MDS.

Reabold ups stake in West Newton gas development field
Reabold Resources announced on Friday that it has completed the acquisition of additional shares in Rathlin Energy UK from Connaught Oil & Gas for £0. 7m, increasing its equity interest in Rathlin to about 79. 8%.

Gemfields reports progress in disrupted fourth quarter
Gemfields reported total auction revenue of $196m for 2024 on Friday, as it continued to invest in the expansion of its Montepuez Ruby Mine (MRM) in Mozambique.

Focusrite trading as expected amid stocking headwinds
Focusrite said in an update on Friday that trading for the first half of its financial year was expected to align with the board’s expectations, with performance anticipated to be weighted towards the second half as channel destocking in the US eased.

Alliance Pharma FY profits seen in line with expectations
International healthcare firm Alliance Pharma said on Friday that FY24 group profits would be in line with expectations despite a modest downturn in revenues.

Avon Technologies trades in line during Q1
Defence products manufacturer Avon Technologies said on Friday that Q1 trading was in line with expectations and that its outlook for the FY remained consistent with previous guidance.